1. Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules.
- Author
-
Gould, Michael K, Smith-Bindman, Rebecca, Kelly, Karen, Altman, Danielle E, Barjaktarevic, Igor, Creekmur, Beth, de Bie, Evan, Dyer, Debra S, Mortani Barbosa, Eduardo J, Mularski, Richard A, Qi, Lihong, Vaszar, Laszlo T, Yu, Sophronia, and Miglioretti, Diana L
- Subjects
Humans ,Lung Neoplasms ,Tomography ,X-Ray Computed ,Neoplasm Staging ,Registries ,Anxiety ,Multicenter Studies as Topic ,Multiple Pulmonary Nodules ,Watchful Waiting ,Pragmatic Clinical Trials as Topic ,lung cancer ,pragmatic trial ,pulmonary nodule ,screening ,surveillance ,Comparative Effectiveness Research ,Health Services ,Clinical Research ,Cancer ,Prevention ,Clinical Trials and Supportive Activities ,Lung ,Biomedical Imaging ,Good Health and Well Being - Abstract
Small pulmonary nodules are most often managed by surveillance imaging with computed tomography (CT) of the chest, but the optimal frequency and duration of surveillance are unknown. The Watch the Spot Trial is a multicenter, pragmatic, comparative-effectiveness trial with cluster randomization by hospital or health system that compares more- versus less-intensive strategies for active surveillance of small pulmonary nodules. The study plans to enroll approximately 35,200 patients with a small pulmonary nodule that is newly detected on chest CT imaging, either incidentally or by screening. Study protocols for more- and less-intensive surveillance were adapted from published guidelines. The primary outcome is the percentage of cancerous nodules that progress beyond American Joint Committee on Cancer seventh edition stage T1a. Secondary outcomes include patient-reported anxiety and emotional distress, nodule-related health care use, radiation exposure, and adherence with the assigned surveillance protocol. Distinctive aspects of the trial include: 1) the pragmatic integration of study procedures into existing clinical workflow; 2) the use of cluster randomization by hospital or health system; 3) the implementation and evaluation of a system-level intervention for protocol-based care; 4) the use of highly efficient, technology-enabled methods to identify and (passively) enroll participants; 5) reliance on data collected as part of routine clinical care, including data from electronic health records and state cancer registries; 6) linkage with state cancer registries for complete ascertainment of the primary study outcome; and 7) intensive engagement with a diverse group of patient and nonpatient stakeholders in the design and execution of the study.
- Published
- 2019